Perspective Therapeutics, Inc.

General ticker "CATX" information:

  • Sector: Health Care
  • Industry: Medical - Devices
  • Capitalization: $245.3M (TTM average)

Perspective Therapeutics, Inc. follows the US Stock Market performance with the rate: 19.5%.

Estimated limits based on current volatility of 4.6%: low 3.77$, high 4.12$

Factors to consider:

  • Earnings expected soon, date: 2026-05-11 bmo
  • Total employees count: 140 as of 2024

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [1.62$, 4.23$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.86$, 4.58$]

Financial Metrics affecting the CATX estimates:

  • Positive: with PPE of -2.0 at the end of fiscal year the price was neutral
  • Negative: Operating cash flow per share per price, % of -40.62 <= 0.07
  • Positive: Operating profit margin, % of 100 > 18.52
  • Positive: Investing cash flow per share per price, % of 20.30 > -0.65
  • Positive: Interest expense per share per price, % of 0.19 <= 0.73
  • Positive: Shareholder equity ratio, % of 77.55 > 64.25
  • Positive: Inventory ratio change, % of -62.63 <= -0.75

Similar symbols

Short-term CATX quotes

Long-term CATX plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $10.46MM $9.14MM
Operating Income $10.46MM $9.14MM
Non-Operating Income $-91.83MM $-113.05MM
Interest Expense $0.05MM $0.38MM
R&D Expense $41.64MM $84.22MM
Income(Loss) $-81.38MM $-103.91MM
Taxes $-2.10MM $-0.79MM
Profit(Loss)* $-79.28MM $-103.12MM
Stockholders Equity $290.67MM $207.03MM
Assets $341.10MM $266.97MM
Operating Cash Flow $-18.29MM $-82.48MM
Capital expenditure $54.41MM $12.75MM
Investing Cash Flow $-218.93MM $41.23MM
Financing Cash Flow $289.38MM $10.30MM
Earnings Per Share** $-1.23 $-1.40

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.